logo icmab ochoa 02 01 logo icmab ochoa 02 01
  • NEWS

Encapsulation of VEGF165 into magnetic PLGA nanocapsules for potential local delivery and bioactivity in human brain endothelial cells

jmc b

E. CarenzaO. JordanP. Martínez-San Segundo, R. JiříkZ. Starčuk jr, G. Borchard, A. Rosell* and A. Roig*  
J. Mater. Chem. B, 2015,3, 2538-2544

DOI: 10.1039/C4TB01895H

Angiogenesis is an important repairing mechanism in response to ischemia. The administration of pro-angiogenic proteins is an attractive therapeutic strategy to enhance angiogenesis after an ischemic event. Their labile structures and short circulation times in vivo are the main obstacles that reduce the bioactivity and dosage of such proteins at the target site. We report on poly(D,L-lactic-co-glycolic acid) (PLGA) nanocapsules (diameter < 200 nm) containing bioactive vascular endothelial growth factor-165 (VEGF165) in the inner core and superparamagnetic iron oxide nanoparticles (SPIONs) embedded in the polymeric shell. The system showed good encapsulation efficiencies for both VEGF165 and SPIONs and a sustained protein release over 14 days. In vitro studies confirmed protein bioactivity in the form of significantly increased proliferation in human microvascular brain endothelial cell cultures once the protein was released. Through magnetic resonance imaging (MRI) measurements we demonstrated excellent T2 contrast image properties with r2 values as high as 213 mM−1 s−1. In addition, magnetic VEGF165-loaded PLGA nanocapsules could be displaced and accumulated under an external magnetic field for guiding and retention purposes. We therefore suggest that using VEGF165-loaded magnetic PLGA nanocapsules may become a new targeted protein-delivery strategy in the development of future pro-angiogenic treatments, as for instance those directed to neurorepair after an ischemic event.


Related Topics: Biomaterials and materials for drug delivery, therapy, diagnostics and sensing

Also on ICMAB...

  • Iron oxide nanoparticles stress the cells

    07 August 2017 951 hit(s)

    ICMAB researchers lead a study on the toxicity of iron oxide nanoparticles based on the analysis of specific genetic markers linked to nanotoxicity in the C. elegans organisms. Part of the experiment, published in the journal Nanotoxicology, has been carried out at the ALBA Synchrotron, in its infrared light MIRAS beamline. The study suggests that nanoparticles can be captured by intestinal cells in their interior, they can interact with cell lipids, and they can activate cellular mechanisms of oxidative stress.
  • Three INPhINIT "la Caixa" Research Fellows will start their PhD at ICMAB on September 2017

    03 August 2017 1001 hit(s)

    We are very happy to announce that, out of a total of 57 PhD positions offered by the INPhINIT doctoral fellowship for outstanding early-stage researchers, the Institute of Materials Science of Barcelona (ICMAB) will welcome three new PhD students, placing the Institute fourth among the 28 centres that were chosen.